Curbing the use of unproven cellular therapies
Interviewee/Contributor
Massimo Dominici
Organisation
International Society Cell and Gene Therapy
Research Directory
Ownership lessons for European biotechs
Interviewee/ContributorJohn RountreeOrganisationNovasectaSourcing antibiotics from the nematode worm
Interviewee/ContributorPhilippe Villain-GuillotOrganisationNosopharm SASInnovation spreads across the oncology sector
Interviewee/ContributorBruno PagliaraOrganisationOn-kòs Pharma ConsultingEuropean pharma plans new strategies for R&D
Interviewee/ContributorJean-Claude MullerOrganisationMedNousUsing nanotechnology to improve AIDS medication
Interviewee/ContributorPeter CharlishOrganisationMedNousPatch up the pain: A case study in transdermal drug delivery
Interviewee/ContributorVasiliki Nikolaou and David HaddletonOrganisationMedherant LtdNon-governmental drug assessments in the US
Interviewee/ContributorSteven PearsonOrganisationInstitute for Clinical and Economic ReviewMandatory joint EU assessments are coming at last
Interviewee/ContributorKaren FinnOrganisationMedNousHow genome editing is impacting cell therapy
Interviewee/ContributorJonathan MooreOrganisationHorizon Discovery Group Plc